Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;14(8):2874-2879.
doi: 10.21037/jtd-22-5.

Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution

Daniel P Dolan  1 , Daniel N Lee  1 , Emily Polhemus  1 , Suden Kucukak  1 , Luis E De León  1 , Daniel Wiener  1 , Michael T Jaklitsch  1 , Scott J Swanson  1 , Abby White  1
Affiliations

Report on lung cancer surgery during COVID-19 pandemic at a high volume US institution

Daniel P Dolan et al. J Thorac Dis. 2022 Aug.

Abstract

Background: The impact of COVID-19 has been felt in every field of medicine. We sought to understand how lung cancer surgery was affected at a high volume institution. We hypothesized that patients would wait longer for surgery, have more advanced tumors, and experience more complications during the COVID-19 crisis.

Methods: A retrospective review was conducted, comparing pathologically confirmed non-small cell lung cancer (NSCLC) surgical cases performed in 2019 to cases performed from March to May 2020, during the height of the COVID-19 crisis. Clinical and pathologic stage, tumor size, time to surgery, follow up time, and complications were evaluated.

Results: A total of 375 cases were performed in 2019 vs. 58 cases in March to May 2020. Overall, there were no differences in the distribution of clinical stages or in the distribution of median wait times to surgery between groups (COVID-19 16.5 days vs. pre-COVID-19 17 days, P=0.54), nor were there differences when subdivided into Stage I-II and Stage III-IV. Case volume was lowest in April 2020 with 6 cases vs. 37 in April 2019, P<0.01. Tumor size was clinically larger in the COVID-19 group (median 2.1 vs. 1.9 cm, P=0.05) but not at final pathology. No differences in complications were observed between groups (COVID-19 31.0% vs. pre-COVID-19 30.9%, P=1.00). No patients from the COVID-19 group tested positive for the disease during their hospital stay or by the median 15 days to first follow-up.

Conclusions: Surgical wait time, pathologic tumor size, and complications were not different among patients undergoing surgery before vs. during the pandemic. Importantly, no patients became infected as a result of their hospital stay. The significant decrease in surgical cases is concerning for untreated cancers that may progress without proper treatment.

Keywords: COVID-19; delays of surgery; thoracic surgery.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at https://jtd.amegroups.com/article/view/10.21037/jtd-22-5/coif). SJS is a consultant for Ethicon and Covidien. The other authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Graphical depiction of non-small cell lung cancer cases during the 2020 COVID-19 pandemic vs. 2019.
See this image and copyright information in PMC

Comment in

References

    1. COVID-19: The US Perspective. The Society of Thoracic Surgeons. Accessed June 26, 2020. Available online: https://www.sts.org/publications/news-surgeons-view/covid-19-us-perspective
    1. Dingemans AC, Soo RA, Jazieh AR, et al. Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol 2020;15:1119-36. 10.1016/j.jtho.2020.05.001 - DOI - PMC - PubMed
    1. Mohammed N, Kestin LL, Grills IS, et al. Rapid disease progression with delay in treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2011;79:466-72. 10.1016/j.ijrobp.2009.11.029 - DOI - PubMed
    1. Samson P, Patel A, Garrett T, et al. Effects of Delayed Surgical Resection on Short-Term and Long-Term Outcomes in Clinical Stage I Non-Small Cell Lung Cancer. Ann Thorac Surg 2015;99:1906-12; discussion 1913. 10.1016/j.athoracsur.2015.02.022 - DOI - PMC - PubMed
    1. Gao SJ, Corso CD, Wang EH, et al. Timing of Surgery after Neoadjuvant Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2017;12:314-22. 10.1016/j.jtho.2016.09.122 - DOI - PubMed